Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction

Proton Pump Inhibitors Accelerate Endothelial SenescenceNovelty and Significance

(2016) Gautham Yepuri et al.   CIRCULATION RESEARCH

Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy

(2016) Muthiah Vaduganathan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012

(2016) Frank Moriarty et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Proton pump inhibitor prescribing patterns in the UK: a primary care database study

(2016) Fatmah Othman et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study

(2016) Jens Sundbøll et al.   BMJ Open

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

(2016) Benjamin Lazarus et al.   JAMA Internal Medicine

Conflicting Results Between Randomized Trials and Observational Studies on the Impact of Proton Pump Inhibitors on Cardiovascular Events When Coadministered With Dual Antiplatelet Therapy

(2015) Chiara Melloni et al.  

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

(2015) Yohannes T Ghebremariam et al.   VASCULAR MEDICINE

Conflicting Results Between Randomized Trials and Observational Studies on the Impact of Proton Pump Inhibitors on Cardiovascular Events When Coadministered With Dual Antiplatelet Therapy

(2015) Chiara Melloni et al.   Circulation-Cardiovascular Quality and Outcomes

Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review

(2015) Matthew W. Sherwood et al.   Journal of the American Heart Association

The Danish National Patient Registry: a review of content, data quality, and research potential

(2015) Morten Schmidt et al.   Clinical Epidemiology

Lexis: AnRClass for Epidemiological Studies with Long-Term Follow-Up

(2015) Martyn Plummer et al.   Journal of Statistical Software

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

(2015) Nigam H. Shah et al.   PLoS One

Revising the link between proton-pump inhibitors and risk of acute myocardial infarction—a case-crossover analysis

(2014) Aleksandra Turkiewicz et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Proton pump inhibitor use represents an independent risk factor for myocardial infarction

(2014) Chia-Jen Shih et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use

(2013) Mette Charlot   ANNALS OF INTERNAL MEDICINE

Unexpected Effect of Proton Pump Inhibitors

(2013) Yohannes T. Ghebremariam et al.   CIRCULATION

Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002–2009

(2013) Stephen R. Rotman et al.   PLoS One

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events

(2013) David N. Juurlink et al.   PLoS One

Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting

(2013) Frederik Hvid-Jensen et al.   Clinical Epidemiology

Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor

(2012) Shaun G. Goodman et al.   CIRCULATION

Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly

(2010) L. Pasina et al.   European Journal of Internal Medicine

Overuse of proton pump inhibitors

(2010) M. Naunton et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Clopidogrel with or without Omeprazole in Coronary Artery Disease

(2010) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Marked increase in proton pump inhibitors use in Australia

(2010) Samantha Hollingworth et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics

(2008) Jon O. Lundberg et al.   NATURE REVIEWS DRUG DISCOVERY